Transforming Preclinical Neuroscience Research

Advanced in vitro Models for Cutting-Edge Research

At ZeNEUROID, we utilize cutting-edge bioengineering technology to create complex neurosphere network brain models derived from mouse and human induced pluripotent stem cells (iPSCs).

Our unique models closely replicate brain behavior and patient-specific traits, providing an advanced platform for drug discovery and therapy development for brain diseases.

Originally developed and patented at Columbia University by our CEO, Dr. M Angeles Rabadan, our models have been continuously improved by our dedicated scientific team.

We now utilize human iPSC-derived and mouse primary cell culture models to bioengineer single 3D and 4D network neuronal models, tailored to meet each customer's needs.

Our Technology

What We Offer

We make your drug development faster, smarter, and more efficient.

Using our advanced in vitro models, we provide comprehensive analyses of neural activity to help you uncover the underlying mechanisms of the neural processes of your interest.

Our high-throughput screening service evaluates potential therapies for a range of brain diseases using our sophisticated in vitro models. We tailor custom assays to assess disease-specific phenotypes and provide the most relevant readouts to you.

Functional Neural Activity Analysis

Drug Screening

Toxicity Assays

Our high-throughput toxicity approach utilizes advanced in vitro models to assess drug safety and efficacy, providing detailed toxicological profiles and helping you uncover the potential of your drug candidates early. We help you make smart decisions and refine your drug discovery strategies.

Our Services

Our Core Principles

ZeNEUROID, a pioneering CRO specialized in advanced iPSC-derived in vitro 3D and 4D brain models, aiming to transform and accelerate preclinical neuroscience.

Accelerating preclinical research with innovative mouse and human-based 4D in vitro platforms that mimic brain function, enabling effective discovery and validation of therapies for neuropsychiatric and neurodegenerative diseases.

Leading neuro-related preclinical research with cutting-edge technology to replace animal research and accelerate the discovery of therapies for brain disorders, faster, smarter, and more efficient.

MISSION

VISION

VALUES

Excellence, Innovation, Integrity,

Collaboration, Transparency,

Advancing Science.

Mission, Vision, Values

While We’re Building the Outside, We’re Hard Science at Work Inside.

We’re in the process of creating a beautiful and informative website to share all about ZeNEUROID’s pioneering work. Stay tuned for exciting updates!

In the meantime, our team is already deep into cutting-edge research and developments to advance treatments for brain diseases.

We are ready to work with you and do science now.

Contact Us

“We understand your challenges.

Together you will do it

Faster, Smarter,

Better.”

Dr. M Angeles Rabadan

ZeNEUROID CEO